VIA
EXAS

Vident Investment Advisory’s Exact Sciences EXAS Stock Holding History

Vident Investment Advisory’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-19,077
Closed -$1.79M – 360
2023
Q2 		$1.79M Buy
19,077
+3,449
+22% +$269K 0.06% 335
2023
Q1 		$1.06M Buy
15,628
+5,133
+49% +$330K 0.03% 510
2022
Q4 		$520K Buy
+10,495
New +$429K 0.02% 704
2022
Q3 		– Sell
-14,384
Closed -$565K – 1176
2022
Q2 		$565K Sell
14,384
-1,028
-7% -$55K 0.02% 836
2022
Q1 		$1.08M Buy
15,412
+53
+0.3% +$3.87K 0.03% 669
2021
Q4 		$1.2M Sell
15,359
-4,010
-21% -$354K 0.03% 639
2021
Q3 		$1.85M Buy
19,369
+5,033
+35% +$531K 0.06% 459
2021
Q2 		$1.78M Buy
14,336
+1,424
+11% +$170K 0.05% 455
2021
Q1 		$1.7M Buy
12,912
+3,705
+40% +$507K 0.06% 441
2020
Q4 		$1.22M Buy
9,207
+4,599
+100% +$556K 0.05% 484
2020
Q3 		$470K Buy
4,608
+577
+14% +$49.8K 0.02% 680
2020
Q2 		$351K Buy
+4,031
New +$322K 0.02% 738
2019
Q3 		– Sell
-3,731
Closed -$440K – 455
2019
Q2 		$440K Sell
3,731
-1,746
-32% -$176K 0.04% 360
2019
Q1 		$474K Sell
5,477
-1,569
-22% -$134K 0.03% 585
2018
Q4 		$445K Sell
7,046
-168
-2% -$11.5K 0.02% 617
2018
Q3 		$569K Buy
7,214
+1,818
+34% +$119K 0.02% 646
2018
Q2 		$323K Buy
5,396
+412
+8% +$22.2K 0.01% 791
2018
Q1 		$224K Buy
+4,984
New +$243K 0.01% 836

Other funds holding EXAS

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vident Investment Advisory's EXAS Position: Q3 2023 in Review

Vident Investment Advisory sold out of Exact Sciences (EXAS) in Q3 2023, closing a stake of 19,077 shares — an estimated $1.79M sold.

Vident Investment Advisory first reported a position in EXAS in Q1 2018 and held it in 18 quarters. The position peaked at $1.85M in Q3 2021. 623 funds tracked by Wall St. Rank hold EXAS as of Q3 2023.

  • Vident Investment Advisory reported no remaining Exact Sciences position as of Q3 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 19,077 Exact Sciences shares in Q3 2023, an estimated $1.79M.
  • Vident Investment Advisory first reported a position in Exact Sciences in Q1 2018 and held it in 18 quarters.
  • Vident Investment Advisory's Exact Sciences position peaked at $1.85M in Q3 2021.
  • 623 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.